LSN News › India

Technology · India Bureau

VIT pro-vice-chancellor calls for shift toward translational research focus

Senior academic leadership at Vellore Institute of Technology has urged students to prioritize translational research that bridges laboratory discoveries with real-world applications. The call came during the Biotech Conclave 2026 held in Chennai.

LSN India · 11 September 2026

VIT pro-vice-chancellor calls for shift toward translational research focus

Dr. T. Thyagarajan, pro-vice-chancellor at VIT, addressed delegates at the biotech industry conference, emphasizing the critical importance of converting fundamental scientific research into practical solutions for societal challenges. Speaking at the event presented by VIT Chennai in association with The Hindu, he highlighted the growing expectations on academic institutions to deliver research outcomes with tangible impact.

Translational research—the process of applying laboratory findings to develop marketable products and treatments—has emerged as a priority area for Indian universities seeking to strengthen their institutional standing and contribute meaningfully to the economy. Dr. Thyagarajan's remarks underscore the institutional shift toward encouraging researchers and students to focus beyond theoretical pursuits.

The Biotech Conclave 2026 brought together industry professionals, academics, and research scholars to discuss emerging trends in biotechnology and the role of educational institutions in nurturing innovation-ready talent. The conclave provided a platform for dialogue on bridging the gap between academia and industry in India's growing biotech sector.

With India positioning itself as a global hub for biotechnology research and development, educational institutions are increasingly expected to align curriculum and research priorities with industry needs and public health requirements. Dr. Thyagarajan's intervention reflects broader institutional efforts to ensure that research investments yield commercially viable and socially beneficial outcomes.